Lung cancer is so closely associated with smoking that people who have never smoked may assume their risk is extremely low.

A rare genetic mutation could help to explain why some people who don’t smoke still develop lung cancer.

A genetic testing program that helps rule out a stem-cell donor due to a genetic risk for developing leukemia was pioneered in the Maritimes, and is helping to improve cancer care.

By Nancy Lapid Sept 18 (Reuters) - Today we feature an important genetic discovery that could help identify never-smokers at high risk of developing lung cancer. We also report on a study that aimed ...

De genetische mutatievariant is in verband gebracht met een 62 keer hoger risico op het ontwikkelen van longkanker.

It can be argued that the devastation of a cancer diagnosis is rooted as much in the prospect of treatment as it is in the prospect of death. In particular, drugs used to treat cancer can cause severe ...

For Josh Henderson, 66, of Olympia, getting genetic testing was a no-brainer. “The first time I came to Fred Hutch, my oncologist suggested it,” said the retired IT manager who received a metastatic ...

As part of breast cancer awareness efforts, the Bayhealth Cancer Institute is hosting a Breast Cancer Genetics event to help ...

Myriad Genetics, Inc. announced in a press release that a study published in JCO Precision Oncology indicates their RiskScore® tool enhances breast cancer screening by aligning clinician ...

NEW YORK, Oct. 3, 2025 /PRNewswire/ -- To honor Breast Cancer Awareness Month, jscreen.org, a national nonprofit that provides accessible genetic testing, partnered with Myriad Genetics and Mount ...

Precision medicine in prostate cancer utilizes genetic testing to identify patients for PARP inhibitor treatment, enhancing personalized care. Genetic testing, including germline and somatic, is ...

Guntur will soon host a groundbreaking genetic testing lab for cancer patients, enhancing local access to advanced ...